WF
ABBV icon

WealthTrust Fairport’s AbbVie ABBV Stock Holding History

WealthTrust Fairport’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$8.5M Sell
105,486
-800
-0.8% -$65.4K 0.8% 37
2018
Q4 		$9.8M Buy
106,286
+439
+0.4% +$38.6K 1.02% 27
2018
Q3 		$10M Buy
105,847
+509
+0.5% +$48.3K 0.93% 28
2018
Q2 		$9.76M Sell
105,338
-1,676
-2% -$164K 0.95% 26
2018
Q1 		$10.1M Sell
107,014
-5,338
-5% -$586K 1.02% 25
2017
Q4 		$10.9M Sell
112,352
-1,988
-2% -$187K 1.1% 22
2017
Q3 		$10.2M Sell
114,340
-576
-0.5% -$43.8K 1.07% 23
2017
Q2 		$8.33M Sell
114,916
-2,410
-2% -$162K 0.91% 30
2017
Q1 		$7.64M Buy
117,326
+981
+0.8% +$61.7K 0.86% 35
2016
Q4 		$7.29M Sell
116,345
-751
-0.6% -$45.8K 0.87% 36
2016
Q3 		$7.38M Buy
117,096
+1,733
+2% +$112K 0.91% 32
2016
Q2 		$7.14M Buy
115,363
+596
+0.5% +$36.3K 0.92% 30
2016
Q1 		$6.55M Buy
114,767
+2,498
+2% +$139K 0.88% 35
2015
Q4 		$6.65M Sell
112,269
-10,520
-9% -$606K 0.91% 34
2015
Q3 		$6.68M Sell
122,789
-9,579
-7% -$624K 0.99% 26
2015
Q2 		$8.89M Buy
132,368
+2,344
+2% +$153K 1.23% 19
2015
Q1 		$7.61M Sell
130,024
-1,522
-1% -$91.9K 1.04% 24
2014
Q4 		$8.61M Sell
131,546
-1,553
-1% -$97.9K 1.22% 21
2014
Q3 		$7.69M Sell
133,099
-250
-0.2% -$13.9K 1.15% 25
2014
Q2 		$7.53M Sell
133,349
-881
-0.7% -$46.2K 1.11% 26
2014
Q1 		$6.9M Sell
134,230
-1,129
-0.8% -$57.1K 1.06% 32
2013
Q4 		$7.15M Buy
135,359
+20,003
+17% +$983K 1.12% 29
2013
Q3 		$5.16M Buy
115,356
+5,271
+5% +$234K 0.85% 45
2013
Q2 		$4.55M Buy
+110,085
New +$4.81M 0.8% 50

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

WealthTrust Fairport's ABBV Position: Q1 2019 in Review

WealthTrust Fairport reduced its AbbVie (ABBV) stake by 0.75% in Q1 2019, selling an estimated $65.4K and leaving 105,486 shares worth $8.5M. The position accounts for 0.8% of the portfolio, ranked #37.

WealthTrust Fairport first reported a position in ABBV in Q2 2013 and has held it in 24 quarters since. The position peaked at $10.9M in Q4 2017. 2,033 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

  • WealthTrust Fairport held 105,486 shares of AbbVie worth $8.5M as of Q1 2019.
  • WealthTrust Fairport sold 800 AbbVie shares in Q1 2019, an estimated $65.4K.
  • AbbVie made up 0.8% of WealthTrust Fairport's portfolio in Q1 2019, its #37 holding.
  • WealthTrust Fairport first reported a position in AbbVie in Q2 2013 and has held it in 24 quarters since.
  • WealthTrust Fairport's AbbVie position peaked at $10.9M in Q4 2017.
  • 2,033 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on WealthTrust Fairport's 13F filing for Q1 2019, filed 15 May 2019.